How to use Riluzol Pmcs
Contents of the leaflet
- Package Leaflet: Information for the User
- Riluzol PMCS, 50 mg, Film-Coated Tablets
- What is Riluzol PMCS and what is it used for
- Important information before taking Riluzol PMCS
- How to take Riluzol PMCS
- Possible side effects
- How to store Riluzol PMCS
- Contents of the pack and other information
Package Leaflet: Information for the User
Riluzol PMCS, 50 mg, Film-Coated Tablets
Riluzolum
Read the package leaflet carefully before taking the medicine, as it contains important information for the patient.
- Keep this package leaflet, you may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If you experience any side effects, including those not listed in this package leaflet, please inform your doctor or pharmacist. See section 4.
Table of Contents of the Package Leaflet
- 1. What is Riluzol PMCS and what is it used for
- 2. Important information before taking Riluzol PMCS
- 3. How to take Riluzol PMCS
- 4. Possible side effects
- 5. How to store Riluzol PMCS
- 6. Contents of the pack and other information
1. What is Riluzol PMCS and what is it used for
The active substance in Riluzol PMCS is riluzole, which acts on the nervous system.
Riluzol PMCS is used in patients with amyotrophic lateral sclerosis (ALS - Amyotrophic Lateral Sclerosis).
Amyotrophic lateral sclerosis is a form of motor neuron disease in which the attack on motor neurons responsible for transmitting information to muscles leads to weakness, muscle atrophy, and paralysis.
The destruction of motor neurons in motor neuron disease may be caused by an excessive amount of glutamate (a neurotransmitter) in the brain and spinal cord. Riluzol PMCS inhibits the release of glutamate, which may help prevent damage to motor neurons.
You should consult your doctor for more information about amyotrophic lateral sclerosis and the reason for prescribing the medicine to you.
2. Important information before taking Riluzol PMCS
When not to take Riluzol PMCS
- if you are allergic to riluzole or any of the other ingredients of this medicine (listed in section 6),
- if you have liver disease or increased activity of certain liver enzymes (aminotransferases) in the blood,
- if you are pregnant or breastfeeding.
Warnings and precautions
Before taking Riluzol PMCS, discuss it with your doctor or pharmacist.
- -if you have any liver problems: yellowing of the skin or whites of the eyes (jaundice), itching, nausea, vomiting,
if you have kidney function disorders,
- if you have a fever: this may indicate a low white blood cell count, which can increase the risk of infection.
If any of the above information applies to you or you are not sure, you should contact your doctor, who will decide what to do.
Children and adolescents
If you are under 18 years of age, taking Riluzol PMCS is not recommended, as there is no information available for this patient group.
Riluzol PMCS and other medicines
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice.
DO NOT take Riluzol PMCS if you are pregnant or think you may be pregnant, or if you are breastfeeding.
Driving and using machines
You can drive or operate machinery if you do not feel dizzy or lightheaded after taking this medicine.
Riluzol PMCS contains sodium
Riluzol PMCS contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is essentially 'sodium-free'.
3. How to take Riluzol PMCS
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The usual dose is one tablet twice a day. Take the tablets orally, every 12 hours, at the same time each day (e.g., morning and evening).
Taking a higher dose of Riluzol PMCS than recommended
If you take more tablets than recommended, contact your doctor or the nearest emergency department immediately.
Missing a dose of Riluzol PMCS
If you forget to take a tablet, skip it completely and take the next tablet at the usual time. Do not take a double dose to make up for the missed dose.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, Riluzol PMCS can cause side effects, although not everybody gets them.
IMPORTANT INFORMATION
Seek medical attention immediately:
- if you have a fever (increased body temperature), as Riluzol PMCS may cause a decrease in white blood cell count. Your doctor may order a blood test to check your white blood cell count, which is important for fighting infections,
- if you experience any of the following symptoms: yellowing of the skin or whites of the eyes (jaundice), itching, nausea, vomiting, as these may be signs of liver disease (hepatitis). While taking Riluzol PMCS, your doctor may order regular blood tests to ensure you do not have liver disease,
- if you have a cough or difficulty breathing, as these may be symptoms of lung disease (interstitial lung disease).
Other side effects
Very common(may affect more than 1 in 10 people):
- feeling tired,
- nausea,
- increased activity of certain liver enzymes (aminotransferases) in the blood.
Common(may affect up to 1 in 10 people):
- dizziness,
- drowsiness,
- headache,
- numbness or tingling of the mouth,
- rapid heartbeat,
- abdominal pain,
- vomiting,
- diarrhea,
- pain.
Uncommon(may affect up to 1 in 100 people):
- anemia,
- allergic reactions,
- pancreatitis.
Rare(cannot be estimated from the available data):
- rash.
Reporting side effects
If you experience any side effects, including those not listed in this package leaflet, please inform your doctor or pharmacist. You can also report side effects directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl
You can also report side effects to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Riluzol PMCS
There are no special precautions for storage of the medicinal product.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton after 'EXP'. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Contents of the pack and other information
What Riluzol PMCS contains
The active substance is riluzole. Each film-coated tablet contains 50 mg of riluzole.
The other ingredients are:
Tablet core: calcium hydrogen phosphate anhydrous, microcrystalline cellulose granules, sodium croscarmellose, colloidal silica anhydrous, magnesium stearate;
Coating: hypromellose 6 cP, titanium dioxide (E171), macrogol 400.
What Riluzol PMCS looks like and contents of the pack
Riluzol PMCS is available as almost white, round, film-coated tablets with a diameter of 8 mm.
Riluzol PMCS is supplied in packs containing 56 or 100 film-coated tablets.
Marketing authorization holder and manufacturer
PRO.MED.CS Praha a.s., Telčská 377/1, Michle, 140 00 Praha 4, Czech Republic
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Austria
Riluzol PMCS 50 mg Filmtabletten
Czech Republic
Riluzol PMCS
Denmark
Riluzol PMCS 50 mg filmovertrukne tabletter
Spain
Riluzol PMCS 50 mg comprimido recubierto con pelicula
Poland
Riluzol PMCS
Romania
Riluzol PMCS 50 mg comprimate filmate
Sweden
Riluzol PMCS 50 mg filmdragerade tabletter
Slovakia
Riluzol PMCS 50 mg filmom obalené tablety
Date of last revision of the package leaflet:

- Country of registration
- Dosage formTablets, 50 mg
- ATC codeN07XX02
- Active substance
- Prescription requiredYes
- Manufacturer
- ImporterPRO.MED.CS. Praha a.s. PRO.MED.CS. Praha a.s.
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to Riluzol PmcsDosage form: Tablets, 50 mgActive substance: riluzolePrescription not requiredDosage form: Tablets, 10 mgActive substance: fampridinePrescription requiredDosage form: Tablets, 10 mgActive substance: fampridineManufacturer: Balkanpharma-Dupnitsa ADPrescription not required
Online doctors for Riluzol Pmcs
Discuss questions about Riluzol Pmcs, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Get Riluzol Pmcs Prescription Online
Fill in a 2-min form
Tell us your symptoms, history, and what medicine you're requesting.
Pick a doctor or let us assign
Choose a specialist or we'll match you with the next available doctor.
Doctor reviews your case
Usually within 30 minutes. They may ask follow-up questions via chat.
Collect from any pharmacy
Electronic prescription sent to your email — valid across Spain.
Frequently Asked Questions
Riluzol Pmcs requires a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.
The active ingredient in Riluzol Pmcs is riluzole. This information helps identify medicines with the same composition but different brand names.
Riluzol Pmcs is manufactured by PRO.MED.CS. Praha a.s. PRO.MED.CS. Praha a.s.. Pharmacy brands and packaging may differ depending on the distributor.
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Riluzol Pmcs is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.
You can buy Riluzol Pmcs in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.
To obtain a prescription, you can use Oladoctor:
Other medicines with the same active substance (riluzole) include Riluzole Sun, Fampridine Sandoz, Fampridine Teva. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
















